
Masimo Corporation MASI
€ 116.68
-1.05%
Quartalsbericht 2025-Q3
hinzugefügt 04.11.2025
Masimo Corporation DPO 2011-2025 | MASI
DPO Jährlich Masimo Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 84.4 | 92.3 | 63.7 | 29.2 | - | 64.5 | 52 | 46 | 42.9 | 70.9 | - | 54.2 | 59 | 67.6 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 92.3 | 29.2 | 60.6 |
DPO Vierteljährlich Masimo Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 82.1 | 86.4 | 83.9 | - | - | - | 156 | - | - | - | - | - | 49.3 | 69.5 | - | 55.8 | 52.5 | 28.1 | - | 82.4 | 57.8 | 56.3 | - | 68.4 | 66.1 | 54.1 | - | 52.8 | 53 | 48.8 | - | 44.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 156 | 28.1 | 65.7 |
DPO anderer Aktien in der Medizinische Instrumente
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
BioLife Solutions
BLFS
|
130 | $ 24.32 | -0.29 % | $ 1.12 B | ||
|
Baxter International
BAX
|
50.7 | $ 19.36 | 1.07 % | $ 9.87 B | ||
|
Becton, Dickinson and Company
BDX
|
59.3 | $ 199.07 | -0.94 % | $ 57.3 B | ||
|
Luminex Corporation
LMNX
|
45.3 | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
218 | - | -9.52 % | $ 20.6 M | ||
|
Ekso Bionics Holdings
EKSO
|
73.7 | $ 4.7 | 0.64 % | $ 94.8 M | ||
|
Antares Pharma, Inc.
ATRS
|
93.7 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
26.4 | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
3.31 | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
61.4 | - | -0.05 % | $ 10.3 B | ||
|
Harvard Bioscience
HBIO
|
47.4 | $ 0.71 | -3.94 % | $ 30.1 M | ||
|
Varian Medical Systems, Inc.
VAR
|
39.5 | - | -0.02 % | $ 16.3 B | ||
|
ICU Medical
ICUI
|
34.9 | $ 147.55 | -0.59 % | $ 3.6 B | ||
|
Alcon
ALC
|
63.6 | $ 79.33 | 0.66 % | $ 40.4 B | ||
|
AtriCure
ATRC
|
81.2 | $ 41.41 | -2.3 % | $ 1.94 B | ||
|
iRhythm Technologies
IRTC
|
12.6 | $ 169.77 | 0.55 % | $ 5.3 B | ||
|
Atrion Corporation
ATRI
|
31.9 | - | - | $ 810 M | ||
|
electroCore
ECOR
|
279 | $ 4.87 | 2.53 % | $ 26.9 K | ||
|
AngioDynamics
ANGO
|
96.2 | $ 13.24 | 0.72 % | $ 541 M | ||
|
Repro Med Systems
KRMD
|
52 | $ 5.69 | -1.64 % | $ 259 M | ||
|
The Cooper Companies
COO
|
72.6 | $ 81.05 | -1.25 % | $ 16.1 B | ||
|
Glaukos Corporation
GKOS
|
67.2 | $ 111.46 | 2.35 % | $ 5.4 B | ||
|
Haemonetics Corporation
HAE
|
41.9 | $ 80.02 | -4.16 % | $ 4.03 B | ||
|
InfuSystem Holdings
INFU
|
62.5 | $ 9.07 | -1.84 % | $ 187 M | ||
|
LeMaitre Vascular
LMAT
|
14.5 | $ 85.18 | 1.4 % | $ 1.91 B | ||
|
Isoray
ISR
|
58.4 | - | 0.03 % | $ 108 M | ||
|
Merit Medical Systems
MMSI
|
34.4 | $ 86.12 | -0.67 % | $ 5.01 B | ||
|
Intuitive Surgical
ISRG
|
25.7 | $ 554.89 | 2.32 % | $ 197 B | ||
|
Microbot Medical
MBOT
|
52.9 | $ 2.24 | -7.06 % | $ 22.8 M | ||
|
OraSure Technologies
OSUR
|
36.6 | $ 2.51 | 0.6 % | $ 187 M | ||
|
Milestone Scientific
MLSS
|
36.5 | $ 0.37 | -7.31 % | $ 29.5 M | ||
|
Nephros
NEPH
|
50.5 | $ 4.84 | -3.59 % | $ 50.3 M | ||
|
NeuroMetrix
NURO
|
78.1 | - | 5.05 % | $ 9.02 M | ||
|
Envista Holdings Corporation
NVST
|
56.8 | $ 21.97 | - | $ 3.78 B | ||
|
ResMed
RMD
|
34.9 | $ 253.24 | 0.35 % | $ 37 B | ||
|
Pro-Dex
PDEX
|
35.4 | $ 42.9 | -1.11 % | $ 141 M | ||
|
Pulse Biosciences
PLSE
|
68.4 | $ 14.26 | 0.14 % | $ 685 M | ||
|
STAAR Surgical Company
STAA
|
74.3 | $ 23.94 | -0.79 % | $ 1.18 B | ||
|
STERIS plc
STE
|
31.8 | $ 252.53 | 0.25 % | $ 24.9 B | ||
|
Predictive Oncology
POAI
|
547 | - | - | $ 32.4 M | ||
|
Stereotaxis
STXS
|
99 | $ 2.36 | -0.42 % | $ 190 M | ||
|
Repligen Corporation
RGEN
|
24.3 | $ 158.39 | 0.64 % | $ 8.83 M | ||
|
Utah Medical Products
UTMD
|
18 | $ 58.18 | 0.14 % | $ 211 M | ||
|
DENTSPLY SIRONA
XRAY
|
54.3 | $ 11.32 | -2.2 % | $ 2.3 B | ||
|
Retractable Technologies
RVP
|
48.6 | $ 0.81 | -1.17 % | $ 24.2 M | ||
|
Teleflex Incorporated
TFX
|
37.1 | $ 126.45 | -0.17 % | $ 5.92 B | ||
|
West Pharmaceutical Services
WST
|
46.4 | $ 266.39 | -0.44 % | $ 19.4 B |